Literature DB >> 18706699

Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition.

Milan Basta1.   

Abstract

Pathogen and self-specific antibodies are known for their ability to trigger generation of active complement fragments that then serve as effectors of cell damage. The remainder of the immunoglobulin pool of the host has the capacity to quench harmful effects of activated complement cascade by preventing active complement fragments from binding to their specific receptors. This scavenging function is mediated by different acceptor sites within the immunoglobulin molecule. Large fragments, such as C3b and C4b are preferentially bound to the Fc region, while biologically potent C3a and C5a anaphylatoxins get neutralized by low-affinity interaction with the constant domain of the F(ab)(2.) The ambivalent effect of immunoglobulins on the complement system implies their role in homeostasis as well as expansion of use of high-dose intravenous immunoglobulins in diseases and states mediated by inappropriate complement activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706699     DOI: 10.1016/j.molimm.2008.07.012

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  21 in total

Review 1.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

2.  Mechanisms of action of immune globulin.

Authors:  E Fernández-Cruz; D Alecsandru; S Sánchez Ramón; S S Ramón
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

Review 3.  Therapeutic potential of complement modulation.

Authors:  Eric Wagner; Michael M Frank
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

Review 4.  Intravenous immunoglobulins--understanding properties and mechanisms.

Authors:  A Durandy; S V Kaveri; T W Kuijpers; M Basta; S Miescher; J V Ravetch; R Rieben
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

5.  Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates.

Authors:  Vinay Nair; Deirdre Sawinski; Enver Akalin; Rex Friedlander; Zeynep Ebcioglu; Vinita Sehgal; Rajani Dinavahi; Rafael Khaim; Scott Ames; Susan Lerner; Barbara Murphy; Jonathan S Bromberg; Peter S Heeger; Bernd Schröppel
Journal:  Clin Transplant       Date:  2012 May-Jun       Impact factor: 2.863

6.  Immunoglobulins in adult sepsis and septic shock.

Authors:  Susanne Toussaint; Herwig Gerlach
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

7.  Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.

Authors:  Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard J Smith; Richard R Kew
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

8.  Biological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile.

Authors:  Vivek R Yadav; Okhil Nag; Vibhudutta Awasthi
Journal:  Artif Organs       Date:  2014-04-22       Impact factor: 3.094

9.  Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.

Authors:  Iglika Djoumerska-Alexieva; Lubka Roumenina; Anastas Pashov; Jordan Dimitrov; Maya Hadzhieva; Sandro Lindig; Elisaveta Voynova; Petya Dimitrova; Nina Ivanovska; Clemens Bockmeyer; Zvetanka Stefanova; Catherine Fitting; Markus Bläss; Ralf Claus; Stephan von Gunten; Srini Kaveri; Jean-Marc Cavaillon; Michael Bauer; Tchavdar Vassilev
Journal:  Mol Med       Date:  2016-03-31       Impact factor: 6.354

Review 10.  The relationship of interacting immunological components in dengue pathogenesis.

Authors:  David G Nielsen
Journal:  Virol J       Date:  2009-11-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.